Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 4, 2008, Pages 457.e1-457.e6

  Abu Rustum, Nadeem R ^a   Iasonos, Alexia ^a   Zhou, Qin ^a   Oke, Eniola ^a   Soslow, Robert A ^a   Alektiar, Kaled M ^a   Chi, Dennis S ^a   Barakat, Richard R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

endometrial cancer; lymph node removal; lymphadenectomy; regression tree; surgery

Indexed keywords

ACCURACY; ADULT; AGE; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT INDICATION;

EID: 41349095877     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.01.010     Document Type: Article

References (15)

1. ACOG Practice Bulletin. Obstet Gynecol 106 (2005) 413-425
2. Barakat R.R., Lev G., Hummer A.J., et al. Twelve-year experience in the management of endometrial cancer: A change in surgical and postoperative radiation approaches. Gynecol Oncol 105 (2007) 150-156
3. Lutman C.V., Havrilesky L.J., Cragun J.M., et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 102 (2006) 92-97
4. Breiman L., Friedman J.H., Stone C.J., and Olshen R.A. Classification and regressions trees (1984), Wadsworth Inc, Belmont (CA)
5. LeBlanc M., and Crowley J. Relative risk tress for censored survival data. Biometrics 48 (1992) 411-425
6. Therneau T.M., and Atkinson E.J. An introduction to recursive partitioning using the rpart routine. Technical report 61 (1997), Mayo Clinic, Section of Statistics, Rochester (MN)
7. Atkinson E.J., and Therneau T.M. An introduction to recursive partitioning using the rpart routine. Technical report 61 (2000), Mayo Clinic, Section of Statistics, Rochester (MN)
8. Kilgore L.C., Partridge E.E., Alvarez R.D., et al. Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56 (1995) 29-33
9. Cragun J.M., Havrilesky L.J., Calingaert B., et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23 (2005) 3668-3675
10. Mariani A., Dowdy S.C., Cliby W.A., et al. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 101 (2006) 200-208
11. Mariani A., Webb M.J., Galli L., and Podratz K.C. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76 (2000) 348-356
12. Le Voyer T.E., Sigurdson E.R., Hanlon A.L., et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21 (2003) 2912-2919
13. Herr H.W., Bochner B.H., Dalbagni G., Donat S.M., Reuter V.E., and Bajorin D.F. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 (2002) 1295-1298
14. Abrey L.E., Ben-Porat L., Panageas K.S., et al. Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol 24 (2006) 5711-5715
15. Abu-Rustum N.R., Alektiar K., Iasonos A., et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 103 (2006) 714-718